Literature DB >> 1997438

Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins.

P K Lee1, J R Deringer, B N Kreiswirth, R P Novick, P M Schlievert.   

Abstract

Toxic shock syndrome toxin 1 (TSST-1) and streptococcal pyrogenic exotoxin A (SPE A) belong to a family of pyrogenic toxins produced by Staphylococcus aureus and Streptococcus pyogenes, respectively. Both toxins are responsible for causing toxic shock syndrome (TSS) and related illnesses, clinically characterized by multiorgan involvement. The most severe TSS symptom is acute hypotension and shock after the initial febrile response. In this study, we examined possible mechanisms of shock development in TSS, particularly the role of T-cell proliferation, endotoxin enhancement by toxins, and capillary leakage. American Dutch belted rabbits, with subcutaneously implanted miniosmotic pumps filled with either TSST-1 or SPE A, served as the animal model. For both TSST-1 and SPE A-treated rabbits, administration of cyclosporin A prevented toxin-induced T-cell proliferation but failed to protect the rabbits. Polymyxin B treatment of rabbits, to neutralize endogenous endotoxin, partially protected rabbits from challenge with either exotoxin; two of six rabbits survived on day 2 when treated with only TSST-1, whereas six of six animals survived after challenge with TSST-1 and polymyxin B. Similarly, with SPE A-treated rabbits, only 1 of 10 animals without polymyxin B treatment survived on day 8, but 4 of 6 rabbits survived on day 8 when given polymyxin B. Fluid replacement was successful in preventing lethality. Twelve of 14 rabbits survived when given TSST-1 with fluid, and all rabbits treated with SPE A and fluid survived. Finally, by using miniosmotic pumps, staphylococcal exfoliative toxin A and concanavalin A were administered to rabbits in an attempt to induce lethality. These two T-cell mitogens caused T-cell proliferation but failed to induce lethality in rabbits. The data suggest that toxin interactions causing vascular leakage and to some extent endotoxin enhancement are of major importance in development of hypotension and shock in TSS. It appears that T-cell proliferation may not contribute significantly to the induction of shock and death.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997438      PMCID: PMC258342          DOI: 10.1128/iai.59.3.879-884.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

Review 1.  Clinical aspects and spectrum of illness of toxic shock syndrome: overview.

Authors:  P J Chesney
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb

2.  Toxin involvement in toxic shock syndrome.

Authors:  B A Crass; M S Bergdoll
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

5.  Pleiotropic loss of activation pathways in a T-cell receptor alpha-chain deletion variant of a cytolytic T-cell clone.

Authors:  A M Schmitt-Verhulst; A Guimezanes; C Boyer; M Poenie; R Tsien; M Buferne; C Hua; L Leserman
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

6.  Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes.

Authors:  N J Poindexter; P M Schlievert
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

7.  Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.

Authors:  J Parsonnet; R K Hickman; D D Eardley; G B Pier
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

8.  Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome.

Authors:  J Parsonnet; Z A Gillis; G B Pier
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

9.  Toxic shock syndrome caused by a strain of Staphylococcus aureus that produces enterotoxin C but not toxic shock syndrome toxin-1.

Authors:  M F Rizkallah; A Tolaymat; J S Martinez; P M Schlievert; E M Ayoub
Journal:  Am J Dis Child       Date:  1989-07

10.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

View more
  26 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  The zinc-dependent major histocompatibility complex class II binding site of streptococcal pyrogenic exotoxin C is critical for maximal superantigen function and toxic activity.

Authors:  Timothy J Tripp; John K McCormick; Jennifer M Webb; Patrick M Schlievert
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

3.  Global repression of exotoxin synthesis by staphylococcal superantigens.

Authors:  Nikola Vojtov; Hope F Ross; Richard P Novick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-10       Impact factor: 11.205

4.  Bacterial superantigen exposure after resolution of influenza virus infection perturbs the virus-specific memory CD8(+)-T-cell repertoire.

Authors:  Chiu-Chen Huang; Sangeeta Shah; Phuong Nguyen; John D Altman; Marcia A Blackman
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

5.  Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein.

Authors:  M A Tomai; P M Schlievert; M Kotb
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

6.  Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin.

Authors:  B A Leonard; P M Schlievert
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

7.  Fluid resuscitation of hypovolemic shock: acute medicine's great triumph for children.

Authors:  Joseph A Carcillo; Robert C Tasker
Journal:  Intensive Care Med       Date:  2006-05-24       Impact factor: 17.440

8.  Streptococcal pyrogenic exotoxin F (SpeF) causes permeabilization of lung blood vessels.

Authors:  M Matsumoto; N Ishikawa; M Saito; K Shibayama; T Horii; K Sato; M Ohta
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

9.  Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence.

Authors:  Stephen B Beres; Gail L Sylva; Kent D Barbian; Benfang Lei; Jessica S Hoff; Nicole D Mammarella; Meng-Yao Liu; James C Smoot; Stephen F Porcella; Larye D Parkins; David S Campbell; Todd M Smith; John K McCormick; Donald Y M Leung; Patrick M Schlievert; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

10.  Intracellular expression of toxic shock syndrome toxin 1 in Saccharomyces cerevisiae.

Authors:  R L Deresiewicz; J A Flaxenburg; M Chan; R W Finberg; D L Kasper
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.